LISATA THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
LISATA THERAPEUTICS, INC. (LSTA) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $0 as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-11-06
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $0.00.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $3.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $6.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $10.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $15.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $22.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $28.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $36.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $45.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $55.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $65.00K 10-K · filed 2023-03-30 |
| 2022-09-30 | $77.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $92.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $105.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $122.00K 10-K · filed 2022-03-22 |
| 2020-12-31 | $55.00K 10-K · filed 2021-02-25 |
| 2019-12-31 | $134.00K 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |